June 12, 2026 · Form 4 insider transaction
Karas Eric sold 25,000 shares of ARS Pharmaceuticals, Inc. at $10.00 per share, a transaction worth $250.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2025.